Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

J. Pierga · SciRah

Researcher profile · Semantic Scholar

J. Pierga

Share profile

J. Pierga — researcher profile on SciRah

h-index: 19
Works: 49
Citations: 1,864

Most-cited papers

Neoadjuvant versus adjuvant chemotherapy in premenopausal patients with tumours considered too large for breast conserving surgery: preliminary results of a randomised trial: S6.
S. Scholl, A. Fourquet, B. Asselain, J. Pierga +11 more
1994European Journal of Cancer445 citations
Semantic Scholar
Second malignancies after breast cancer: the impact of different treatment modalities
Y. Kirova, Y. de Rycke, L. Gambotti, J. Pierga +2 more
2008British Journal of Cancer303 citations Open access
Semantic Scholar
Breast tumour response to primary chemotherapy predicts local and distant control as well as survival.
S. Scholl, J. Pierga, B. Asselain, P. Beuzeboc +8 more
1995European Journal of Cancer160 citations
Semantic Scholar
Detection of MUC1-expressing mammary carcinoma cells in the peripheral blood of breast cancer patients by real-time polymerase chain reaction.
P. de Cremoux, J. Extra, M. Denis, J. Pierga +8 more
2000Clinical Cancer Research113 citations
Semantic Scholar
Platinum-based chemotherapy in metastatic triple-negative breast cancer: the Institut Curie experience.
L. Staudacher, P. Cottu, V. Diéras, A. Vincent-Salomon +6 more
2011Annals of Oncology91 citations Open access
Semantic Scholar
Liver metastases from breast cancer: Surgical resection or not? A case-matched control study in highly selected patients.
P. Mariani, V. Servois, Y. de Rycke, S. Bennett +6 more
2013European Journal of Surgical Oncology76 citations
Semantic Scholar
Efficacy and tolerance of vinorelbine and fluorouracil combination as first-line chemotherapy of advanced breast cancer: results of a phase II study using a sequential group method.
V. Diéras, J. Extra, É. Bellissant, M. Espié +5 more
1996Journal of Clinical Oncology75 citations
Semantic Scholar
HER2 status of bone marrow micrometastasis and their corresponding primary tumours in a pilot study of 27 cases: a possible tool for anti-HER2 therapy management?
A. Vincent-Salomon, J. Pierga, J. Couturier, C. D. d'Enghien +7 more
2007British Journal of Cancer61 citations Open access
Semantic Scholar
A gene signature to predict high tumor-infiltrating lymphocytes after neoadjuvant chemotherapy and outcome in patients with triple-negative breast cancer
C. Criscitiello, M. Bayar, G. Curigliano, F. Symmans +11 more
2018Annals of Oncology58 citations Open access
Semantic Scholar
Microarray-based comparative genomic hybridisation of breast cancer patients receiving neoadjuvant chemotherapy
J. Pierga, J. Reis-Filho, S. Cleator, T. Dexter +11 more
2006British Journal of Cancer57 citations Open access
Semantic Scholar
Response to chemotherapy is a major parameter-influencing long-term survival of metastatic breast cancer patients.
J. Pierga, M. Robain, M. Jouve, B. Asselain +7 more
2001Annals of Oncology46 citations Open access
Semantic Scholar
Long term prognostic value of growth fraction determination by Ki-67 immunostaining in primary operable breast cancer
J. Pierga, A. Leroyer, P. Viehl, V. Mosseri +2 more
2005Breast Cancer Research and Treatment39 citations
Semantic Scholar
Clinical significance of proliferative potential of occult metastatic cells in bone marrow of patients with breast cancer
J. Pierga, C. Bonneton, H. Magdelenat, A. Vincent-Salomon +3 more
2003British Journal of Cancer34 citations Open access
Semantic Scholar
Efficacy and safety of single agent capecitabine in pretreated metastatic breast cancer patients from the French compassionate use program
J. Pierga, P. Fumoleau, Y. Brewer, L. Zelek +9 more
2004Breast Cancer Research and Treatment30 citations
Semantic Scholar
Predictive factors of response to first-line chemotherapy in 1426 women with metastatic breast cancer.
M. Robain, J. Pierga, M. Jouve, B. Asselain +7 more
2000European Journal of Cancer27 citations
Semantic Scholar
Neoadjuvant chemotherapy in young breast cancer patients: correlation between response and relapse?
A. Braud, B. Asselain, S. Scholl, A. de la Rochefordière +7 more
1999European Journal of Cancer27 citations
Semantic Scholar
A phase I clinical and pharmacokinetic study of capecitabine (Xeloda®) and irinotecan combination therapy (XELIRI) in patients with metastatic gastrointestinal tumours
J. Delord, J. Pierga, V. Diéras, F. Bertheault-Cvitkovic +10 more
2005British Journal of Cancer26 citations Open access
Semantic Scholar
Efficacy and safety of bevacizumab (BEV)-based combination regimens in patients with metastatic colorectal cancer (mCRC): Randomized phase II study of BEV + FOLFIRI versus BEV + XELIRI (FNCLCC ACCORD 13/0503 study).
M. Ducreux, A. Adenis, J. Mendiboure, E. François +6 more
2016Journal of Clinical Oncology25 citations
Semantic Scholar
Treatment of advanced or recurrent endometrial carcinoma with combination of etoposide, cisplatin, and 5-fluorouracil: a phase II study.
J. Pierga, V. Diéras, D. Paraiso, Thierry Dorval +6 more
1996Gynecologic Oncology19 citations
Semantic Scholar
UNICANCER-PEGASE 07 study: a randomized phase III trial evaluating postoperative docetaxel-5FU regimen after neoadjuvant dose-intense chemotherapy for treatment of inflammatory breast cancer.
Anthony Gonçalves, J. Pierga, J. Ferrero, M. Mouret-Reynier +14 more
2015Annals of Oncology18 citations Open access
Semantic Scholar
Prognostic value of cytokeratin 19 fragment (CYFRA 21-1) and cytokeratin-positive cells in bone marrow samples of breast cancer patients.
J. Pierga, L. Deneux, C. Bonneton, A. Vincent-Salomon +5 more
2004International Journal of Biological Markers17 citations
Semantic Scholar
Plasminogen activator inhibitor-1 (PAI-1) is not related to response to neoadjuvant chemotherapy in breast cancer.
J. Pierga, C. Lainé-Bidron, P. Beuzeboc, P. de Cremoux +2 more
1997British Journal of Cancer17 citations Open access
Semantic Scholar
Phase II trial of doxorubicin, 5-fluorouracil, etoposide, and cisplatin in advanced or recurrent endometrial carcinoma.
J. Pierga, V. Diéras, P. Beuzeboc, T. Dorval +5 more
1997Gynecologic Oncology15 citations
Semantic Scholar
Challenges in the stratification of breast tumors for tailored therapies.
J. P. Thiery, X. Sastre-Garau, B. Vincent-Salomon, X. Sigal-Zafrani +13 more
2006Bulletin du Cancer14 citations
Semantic Scholar
[Applications of antisense oligonucleotides in oncology].
J. Pierga, S. Cammilleri, B. Benyahia, H. Magdelenat
1994Bulletin du Cancer14 citations
Semantic Scholar
Is primary chemotherapy useful for all patients with primary invasive breast cancer?
S. Scholl, P. Beuzeboc, A. Harris, J. Pierga +6 more
1998Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer12 citations
Semantic Scholar
転移性結腸直腸癌患者におけるベバシズマブを基本とした併用レジメンの有効性と安全性:ベバシズマブ+FOLFIR対ベバシズマブ+XELIRIのランダム化第二相試験(FNCLCC ACCORD 13/0503研究)の予備結果
M. Ducreux, A. Adenis, J. Pignon, E. François +6 more
200911 citations
Semantic Scholar
Randomized trial comparing protracted infusion of 5-fluorouracil with weekly doxorubicin and cyclophosphamide with a monthly bolus FAC regimen in metastatic breast carcinoma (SPM90).
J. Pierga, M. Jouve, B. Asselain, Alain Livartowski +7 more
1998British Journal of Cancer10 citations Open access
Semantic Scholar
275P A phase II study of LAG525 in combination with spartalizumab (PDR001), PDR001 and carboplatin (Carbo), or Carbo, as first- or second-line therapy in patients (Pts) with advanced (Adv) triple-negative breast cancer (tnbc)
L. Carey, J. Pierga, S. Kümmel, G. Jerusalem +6 more
2021Annals of Oncology7 citations Open access
Semantic Scholar
Primary efficacy analysis of a phase II study of neoadjuvant bevacizumab (BEV), chemotherapy (CT), and trastuzumab (H) in HER2-positive inflammatory breast cancer (IBC): BEVERLY2 study.
P. Viens, J. Pierga, T. Petit, T. Delozier +8 more
2011Journal of Clinical Oncology5 citations
Semantic Scholar
[Chemotherapy of metastatic endometrial carcinoma. Review of the literature].
J. Pierga, V. Diéras, D. Paraiso, P. Pouillart
1995Bulletin du Cancer4 citations
Semantic Scholar
Prediction of long-term cumulative incidences based on short-term parametric model for competing risks: application in early breast cancer
B. Cabarrou, Lisa Belin, S. M. Somda, M. Falcou +5 more
2016Breast Cancer Research and Treatment3 citations
Semantic Scholar
Imaging and biodistribution of 125I tyramine oligonucleotide in nude mice bearing human breast tumor. Preliminary report.
S. Cammilleri, B. Perdereau, F. Brixy, J. Pierga +3 more
1996Bulletin du Cancer2 citations
Semantic Scholar
Applications of antisense oligonucleotides in oncology.
J. Pierga, H. Magdelénat
1994Cellular and Molecular Biology2 citations
Semantic Scholar
333PCIRCULATING TUMOR CELL COUNT AT BASELINE IS AN INDEPENDENT PROGNOSTIC FACTOR FROM PATHOLOGICAL COMPLETE RESPONSE AMONG PATIENTS TREATED FOR PRIMARY INFLAMMATORY HER2-POSITIVE BREAST CANCER: SURVIVAL RESULTS OF THE BEVERLY-2 STUDY.
J. Pierga, T. Petit, C. Lévy, J. Ferrero +11 more
2014Annals of Oncology1 citations Open access
Semantic Scholar
HER2 gene status assessment in micrometastatic cells in bone marrow (BM) of breast cancer patients by fluorescence in situ hybridization (FISH).
A. Vincent-Salomon, J. Couturier, C. Nos, X. Sastre-Garau +5 more
2004Journal of Clinical Oncology1 citations
Semantic Scholar
Transcriptomic Insights into Lobular Breast Cancer Biology and Patient Outcomes: Analysis of the MINDACT Clinical Trial
C. Desmedt, Ha-Linh Nguyen, F. Richard, Sabine C. Linn +16 more
2026Clinical Cancer Research0 citations Open access
Semantic Scholar
One-Year Toxicity Report of the RADIOPARP Phase I Trial Evaluating Olaparib With Radiotherapy for Triple Negative Breast Cancer.
P. Loap, D. Loirat, F. Berger, M. Rodrigues +13 more
2021International Journal of Radiation Oncology, Biology, Physics0 citations Open access
Semantic Scholar
Updated results of the MINDACT trial: 70-gene signature to guide de-escalation of chemotherapy in early breast cancer
E. Rutgers, L. van 't Veer, C. Poncet, J.Lopes Cardozo +16 more
20200 citations
Semantic Scholar
Febrile neutropenia in adjuvant and neoadjuvant chemotherapy for breast cancer: a retrospective study in routine clinical practice from a single institution
J. Bacrie, M. Laurans, P. Iorio, E. Fourme +8 more
20170 citations
Semantic Scholar
404PBEVACIZUMAB AND PACLITAXEL AS FIRST LINE CHEMOTHERAPY OF HER2 NEGATIVE ADVANCED BREAST CANCER (ABC): RESULTS OF AN OBSERVATIONAL INSTITUTIONAL STUDY.
S. Pop, M. Dujaric, P. Beuzeboc, L. Mignot +9 more
2014Annals of Oncology0 citations Open access
Semantic Scholar
357PDDETERMINANTS OF CENTRAL NERVOUS SYSTEM (CNS) METASTASES IN A COHORT OF 620 EARLY BREAST CANCER PATIENTS AFTER 11 YEARS FOLLOW UP: ROLE OF DISSEMINATED TUMOR CELL (DTC) IN BONE MARROW (BM) DETECTED AT PRIMARY DIAGNOSIS.
D. Loirat, F. Bidard, Léonor Chaltiel, F. Berger +8 more
2014Annals of Oncology0 citations Open access
Semantic Scholar
Surgical resection of liver metastasis of breast cancer: A multidisciplinary approach-Study case-control.
P. Mariani, V. Servois, Y. de Ricke, M. Laé +7 more
2011Journal of Clinical Oncology0 citations
Semantic Scholar
Quantitative density evaluation of liver metastases on CT scan: A new tool to evaluate early the benefit of bevacizumab plus chemothrapy regimen.
E. Assenat, B. Gallix, M. Ducreux, A. René +9 more
2011Journal of Clinical Oncology0 citations
Semantic Scholar
A retrospective study of parameters influencing survival after surgical resection of lung metastases of bone and soft tissue sarcomas.
S. Piperno-Neumann, K. Homicsko, S. Mussot, P. Anract +4 more
2009Journal of Clinical Oncology0 citations
Semantic Scholar
Traitement adjuvant du cancer du sein n’exprimant pas HER2
J. Pierga
20070 citations
Semantic Scholar
Facteurs de risque et étude bactériologique d'une épidémie de diarrhée à Clostridium difficile dans un service d'oncologie adulte
E. Blot, Marie-Christine Escande, C. Grandpeix, F. Barbut +9 more
20000 citations
Semantic Scholar
Dose-intense salvage therapy after neoadjuvant chemotherapy: feasibility and preliminary results
T. Palangié, J. Pierga, P. Pouillart
1999Cancer Chemotherapy and Pharmacology0 citations
Semantic Scholar
Overexpression of PDGF receptor β in dermal fibroblasts of lymphangitic post radiotherapy relapses of breast carcinoma
J. Pierga, B. Benyahia, S. Cammilleri, T. Palangié +3 more
19970 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

P. Beuzeboc×13
Invite
P. Beuzeboc — researcher profile on SciRah
T. Palangié×11
Invite
T. Palangié — researcher profile on SciRah
S. Scholl×10
Invite
S. Scholl — researcher profile on SciRah
M. Jouve×9
Invite
M. Jouve — researcher profile on SciRah

×9

Invite

V. Diéras — researcher profile on SciRah

P. Pouillart×9

Invite

P. Pouillart — researcher profile on SciRah

P. Pouillart×8

Invite

P. Pouillart — researcher profile on SciRah

Invite

T. Dorval — researcher profile on SciRah

A. Vincent-Salomon×7

Invite

A. Vincent-Salomon — researcher profile on SciRah

Invite

B. Asselain — researcher profile on SciRah

Invite

B. Asselain — researcher profile on SciRah

Invite

C. Nos — researcher profile on SciRah